Induction Healthcare Group PLC Director/PDMR Shareholding (3829P)
June 09 2020 - 3:34AM
UK Regulatory
TIDMINHC
RNS Number : 3829P
Induction Healthcare Group PLC
09 June 2020
9 June 2020
Induction Healthcare Group PLC
("Induction", the "Company" or the "Group")
Director/PDMR Shareholdings
Further to the Company's announcement on 5 June 2020 (RNS number
1155P), the Company hereby provides the following notification,
made in accordance with the requirements of the EU Market Abuse
Regulation.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name James Balmain
---------------------------------------------- -------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------
a) Position/status Joint Group CEO
---------------------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
---------------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------
a) Name Induction Healthcare Group PLC
---------------------------------------------- -------------------------------------------
b) Legal Entity Identifier 213800RY96GCZQW5TP19
---------------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.5 pence each of
financial instrument, the Company
type of instrument
Identification code GB00BJ0M3545
---------------------------------------------- -------------------------------------------
b) Nature of the transaction Consideration shares issued as a result
of Induction's acquisition of Zesty
Limited.
---------------------------------------------- -------------------------------------------
c) Currency GBP
---------------------------------------------- -------------------------------------------
d) Price(s) and volume(s) Price Volume
---------------------------------------------- -------------------- ---------------------
N/A 699,391
------------------------------------------------------------------------ ---------------------
e) Aggregated information
- Aggregated volume N/A
- Price
- Aggregated total
---------------------------------------------- -------------------------------------------
f) Date of the transaction 9 June 2020
---------------------------------------------- -------------------------------------------
g) Place of the transaction Outside of trading venue
---------------------------------------------- -------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Andrew Williams
---------------------------------------------- -------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
---------------------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
---------------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------
a) Name Induction Healthcare Group PLC
---------------------------------------------- -------------------------------------------
b) Legal Entity Identifier 213800RY96GCZQW5TP19
---------------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.5 pence each of
financial instrument, the Company
type of instrument
Identification code GB00BJ0M3545
---------------------------------------------- -------------------------------------------
b) Nature of the transaction Consideration shares issued as a result
of Induction's acquisition of Zesty
Limited.
---------------------------------------------- -------------------------------------------
c) Currency GBP
---------------------------------------------- -------------------------------------------
d) Price(s) and volume(s) Price Volume
---------------------------------------------- -------------------- ---------------------
N/A 419,495
------------------------------------------------------------------------ ---------------------
e) Aggregated information
- Aggregated volume N/A
- Price
- Aggregated total
---------------------------------------------- -------------------------------------------
f) Date of the transaction 9 June 2020
---------------------------------------------- -------------------------------------------
g) Place of the transaction Outside of trading venue
---------------------------------------------- -------------------------------------------
-Ends-
ENQUIRIES
Induction Healthcare Group PLC via FTI Consulting
Shelley Fraser, Chief Financial Officer
Numis Securities (Nominated Adviser
and Broker)
James Black / Freddie Barnfield / Huw
Jeremy / Matthew Jones +44 (0) 207 260 1000
FTI Consulting
Jamie Ricketts / Elena Kalinskaya / Sam
Purewal / Mary Whittow +44 (0) 203 727 1000
About Induction
Induction Healthcare Group PLC is a leading healthcare
technology company that helps healthcare professionals deliver
better care more efficiently. The Group has two platforms,
Induction and MicroGuide, that support healthcare professionals in
multiple markets, including UK, Ireland, Australia and South
Africa. Induction is the number one healthcare collaboration app in
the UK. The app helps over 140,000 users - mostly doctors - to
increase productivity and enhance communication by securely sharing
phone numbers and bleeps, bookmarks, documents and messages in a
clinical setting. The MicroGuide platform provides medical
organisations with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. The Induction app is used by the
majority of hospital doctors within the NHS. The MicroGuide
platform is used by the majority of trusts within the NHS.
As at 1 May 2020, the Induction app had 140,819 registered
users, primarily in the UK. The registered user base grew by 67.2%
from 1 May 2019 to 1 May 2020.
As at 1 May 2020, the MicroGuide app had 173,196 registered
users, primarily in the UK. The registered user base grew by 36.2%
from 1 May 2019 to 1 May 2020.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHGRGDLDXGDGGC
(END) Dow Jones Newswires
June 09, 2020 03:34 ET (07:34 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024
